Stock Picking: Aurobindo Pharma and NMDC Highlighted as Potential Investment Opportunities by Nagaraj Shetti

Indian Stock Market Update - Thursday, [Date]

Market Performance:

• Sensex: Reversed early gains and ended the day down by 281.81 points or 0.34% at 81,994.26.
• Nifty 50: Fell by 62 points or 0.25% to 25,420.95.

Market Drivers:

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

• Profit Booking: Investors took profits across multiple sectors, including FMCG, metals, and real estate stocks.
• Global Indicators: Weak signals from major Asian stock indices, including Shanghai's SSE Composite and Hong Kong's Hang Seng, affected investor sentiment.
• Crude Oil Prices: Increased by approximately 7-month highs due to uncertainties regarding US-Iran nuclear negotiations and supply disruptions.
• Geopolitical Tensions: Revived worries about the US-Iran nuclear situation made investors wary and contributed to the market's subdued performance.

Market Views:

• Nagaraj Shetti, Senior Technical Research Analyst, HDFC Securities: The market is currently trading higher by 80 points but is expected to face a strong hurdle around 25,600-25,650 levels in the short term.
• Technical Picks:
  • Aurobindo Pharma Ltd: Recommended to buy at ₹1,243 with a target of ₹1,305 and a stop-loss of ₹1,205. Timeframe: 1 week.
  • NMDC Ltd: Recommended to buy at ₹82.90 with a target of ₹88 and a stop-loss of ₹80. Timeframe: 1 week.